These findings suggest that a better understanding of the interplay between mutp53, HSF1/HSP, and UPR response may unveil new possible druggable targets to reduce cancer cell adaptation to stresses and thus tumor progression and chemoresistance [16]. The gene discussed is HSF1; the disease is cancer.